(Q28238963)

1

0 references

Xiaojin Liu

2

0 references

Yanchun Zhou

3

0 references

Shao Bo Su

Journal of Leukocyte Biology

4

0 references

language of work or name

English

0 references

publication date

July 2009

0 references

published in

0 references

volume

86

0 references

page(s)

23-32

0 references

issue

1

0 references

cites work

Virus interference. I. The interferon

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IFN-lambda: novel antiviral cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Interferons, interferon-like cytokines, and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Genes for the trophoblast interferons in sheep, goat, and musk ox and distribution of related genes among mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IFN-zeta/ limitin: a member of type I IFN with mild lympho-myelosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Regulation of interferon-gamma during innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IL-28, IL-29 and their class II cytokine receptor IL-28R

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Interleukin-10 and related cytokines and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

On-column refolding purification and characterization of recombinant human interferon-lambda1 produced in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IL-28 and IL-29: newcomers to the interferon family

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

The newest interleukins: recent additions to the ever-growing cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Molecular cloning, expression, and characterization of chicken IFN -lambda

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IFN regulation and functions in myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Human interferon-lambda3 is a potent member of the type III interferon family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Biological activity of interleukins-28 and -29: comparison with type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Purification and characterization of recombinant human interleukin-29 expressed in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Purification and characterization of prokaryotically expressed human interferon-lambda2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Lambda interferon inhibits hepatitis B and C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Antiviral activity of type I interferons and interleukins 29 and 28a (type III interferons) against Apeu virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-gamma-induced nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Antitumor activity of IFN-lambda in murine tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Regulation of apoptosis by type III interferons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Type III and I interferons increase HIV uptake and replication in human cells that overexpress CD4, CCR5, and CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29)

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Production, characterization, and applications of two novel monoclonal antibodies against human interleukin-28A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Innate immunity in the pathogenesis of virus-induced asthma exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Immunotherapeutic approaches in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Cytokine therapeutics: lessons from interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Neuropsychiatric adverse effects of interferon-alpha: recognition and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Type I interferon response in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761

Role of deficient type III interferon-λ production in asthma exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1208761